Neratinib in Combination With Ruxolitinib in Patients With mTNBC (clinicaltrials.gov) - Oct 14, 2026 - P1 | N=20 | Recruiting | Sponsor: Baylor Research Institute | Trial completion date: Dec 2026 ➔ Dec 2027 | Trial primary completion date: Jun 2026 ➔ Jun 2027
Trial completion date • Trial primary completion date • Breast Cancer • Hormone Receptor Negative Breast Cancer • Oncology • Solid Tumor • Triple Negative Breast Cancer • ER
|